Seelos Therapeutics, Inc. (SEEL)
Largest Insider Buys in Sector
SEEL Stock Price History Chart
SEEL Stock Performance
About Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Insider Activity of Seelos Therapeutics, Inc.
Over the last 12 months, insiders at Seelos Therapeutics, Inc. have bought $200,222 and sold $0 worth of Seelos Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Seelos Therapeutics, Inc. have bought $129,272 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Golembiewski Michael Joseph (Chief Financial Officer) — $100,223. Mehra Raj (See Remarks) — $99,999.
The last purchase of 75,757 shares for transaction amount of $99,999 was made by Mehra Raj (See Remarks) on 2023‑12‑01.
List of Insider Buy and Sell Transactions, Seelos Therapeutics, Inc.
| 2023-12-01 | Mehra Raj | See Remarks | 75,757 1.2916% | $1.32 | $99,999 | -43.52% | ||
| 2023-11-30 | Golembiewski Michael Joseph | Chief Financial Officer | 83,000 1.4318% | $1.21 | $100,223 | -37.40% | ||
| 2022-06-01 | O'Connor Daniel J. | 16,000 0.0153% | $0.61 | $9,789 | +41.60% | |||
| 2022-05-26 | DALESANDRO MARGARET | 35,000 0.0332% | $0.60 | $20,965 | +42.78% | |||
| 2022-03-31 | Mehra Raj | See Remarks | 66,667 0.064% | $0.85 | $56,840 | -0.18% | ||
| 2020-02-13 | Mehra Raj | See Remarks | 133,333 0.3566% | $0.75 | $100,000 | +17.09% | ||
| 2017-08-31 | DENNER ALEXANDER J | 10 percent owner | 6,104 0.0462% | $1.63 | $9,950 | -46.62% | ||
| 2016-03-03 | DENNER ALEXANDER J | 10 percent owner | 6.65M 10.1208% | $0.88 | $5.85M | -67.62% | ||
| 2016-01-12 | DENNER ALEXANDER J | 10 percent owner | 1.31M 2.3739% | $0.88 | $1.15M | -56.82% | ||
| 2014-12-29 | Dorsey Brian | Chief Development Officer | 10,000 0.0267% | $1.05 | $10,481 | +59.09% | ||
| 2014-12-22 | Pascoe Richard W | Chief Executive Officer | 10,000 0.0261% | $1.02 | $10,217 | +59.09% | ||
| 2014-10-23 | SMITH SANDFORD D | director | 18,200 0.0466% | $1.59 | $28,998 | +1.11% | ||
| 2014-10-22 | Pascoe Richard W | Chief Executive Officer | 12,000 0.0297% | $1.51 | $18,120 | +3.08% | ||
| 2014-10-22 | Ray Rusty | director | 3,500 0.0086% | $1.50 | $5,250 | +3.08% | ||
| 2014-10-22 | WIERENGA WENDALL | director | 20,000 0.0498% | $1.52 | $30,364 | +3.08% | ||
| 2014-10-22 | SMITH SANDFORD D | director | 8,300 0.0207% | $1.52 | $12,651 | +3.08% | ||
| 2014-01-03 | Sale | Oppenheim Leonard A | director | 15,212 0.0402% | $2.49 | $37,928 | -16.06% | |
| 2013-12-26 | Sale | XANTHOPOULOS KLEANTHIS G | director | 17,184 0.0477% | $2.55 | $43,819 | -20.41% | |
| 2013-06-21 | Sale | XANTHOPOULOS KLEANTHIS G | director | 2,864 0.0089% | $2.52 | $7,217 | -10.89% | |
| 2013-05-23 | Pascoe Richard W | Chief Executive Officer | 35,000 0.1147% | $2.85 | $99,750 | -16.51% |
Insider Historical Profitability
| Mehra Raj | See Remarks | 185142 1.3533% | $0.63 | 3 | 0 | +8.45% |
| Golembiewski Michael Joseph | Chief Financial Officer | 86450 0.6319% | $0.63 | 1 | 0 | |
| MAY JACOB | 5714630 41.7718% | $0.63 | 91 | 2 | ||
| Southpoint Capital Advisors LP | 10 percent owner | 3666237 26.7988% | $0.63 | 1 | 0 | |
| Damaj Bassam | President and CEO | 1611747 11.7813% | $0.63 | 2 | 0 | |
| DENNER ALEXANDER J | 10 percent owner | 1447906 10.5836% | $0.63 | 3 | 0 | |
| BERMAN RICHARD J | director | 307161 2.2452% | $0.63 | 0 | 1 | |
| Cox Edward M. | VP of Corporate Development | 158541 1.1589% | $0.63 | 1 | 0 | |
| XANTHOPOULOS KLEANTHIS G | director | 55735 0.4074% | $0.63 | 0 | 7 | |
| Pascoe Richard W | Chief Executive Officer | 47000 0.3436% | $0.63 | 3 | 0 | |
| DALESANDRO MARGARET | 35000 0.2558% | $0.63 | 1 | 0 | +42.78% | |
| Ray Rusty | director | 32352 0.2365% | $0.63 | 3 | 0 | |
| SMITH SANDFORD D | director | 26500 0.1937% | $0.63 | 2 | 0 | |
| Oppenheim Leonard A | director | 20449 0.1495% | $0.63 | 0 | 2 | |
| WIERENGA WENDALL | director | 20000 0.1462% | $0.63 | 1 | 0 | |
| Martin Steven Robert | Senior VP & CFO | 20000 0.1462% | $0.63 | 1 | 0 | |
| O'Connor Daniel J. | 16000 0.117% | $0.63 | 1 | 0 | +41.6% | |
| Dorsey Brian | Chief Development Officer | 10000 0.0731% | $0.63 | 1 | 0 | |
| Pandya Hemanshu | 0 0% | $0.63 | 0 | 1 |
Institutional Investor Ownership
| Wealth Effects Llc | $275.8M | 17.9 | 466,660 | +104.14% | +$140.7M | 51.16 | |
| AdvisorShares | $273.45M | 17.74 | 462,694 | +155.27% | +$166.33M | 23.7 | |
| Balyasny Asset Management Llc | $224.13M | 14.54 | 379,239 | +43.24% | +$67.66M | 0.6 | |
| The Vanguard Group | $165.99M | 10.77 | 280,866 | -1.06% | -$1.78M | <0.01 | |
| Modera Wealth Management | $93.15M | 6.04 | 157,617 | +126.05% | +$51.94M | 1.57 | |
| Morgan Stanley | $74.5M | 4.83 | 126,064 | +79.67% | +$33.04M | 0.01 | |
| Geode Capital Management | $60.53M | 3.93 | 102,408 | +249% | +$43.19M | 0.01 | |
| BlackRock | $33.07M | 2.15 | 55,961 | <0.01% | -$1,773.00 | <0.01 | |
| Strategic Family Wealth Counselors, LLC | $17.74M | 1.15 | 30,010 | 0% | +$0 | 6.76 | |
| Jane Street Capital | $13.6M | 0.88 | 23,009 | New | +$13.6M | 0.02 | |
| Xtx Topco Ltd | $9.5M | 0.62 | 16,071 | New | +$9.5M | 0.52 | |
| Two Sigma | $7.73M | 0.5 | 13,085 | -48.17% | -$7.19M | 0.01 | |
| State Street | $7.65M | 0.5 | 12,948 | 0% | +$0 | <0.0001 | |
| CRA Financial Services LLC | $7.03M | 0.46 | 11,889 | New | +$7.03M | 1.6 | |
| Tower Research Capital | $6.22M | 0.4 | 10,517 | +99.19% | +$3.1M | 0.06 | |
| UBS | $6.01M | 0.39 | 10,166 | +2,397.79% | +$5.77M | <0.01 | |
| Wealth Enhancement Advisory Services LLC | $5.92M | 0.38 | 10,018 | New | +$5.92M | 0.02 | |
| Advisor Group Holdings Inc | $4.76M | 0.32 | 8,233 | -5.87% | -$296,472.00 | 0.01 | |
| Carmichael Hill & Associates | $4.73M | 0.31 | 8,000 | +60% | +$1.77M | 2.02 | |
| JPMorgan Chase | $2.38M | 0.16 | 4,032 | +100.1% | +$1.19M | <0.0001 | |
| Bank of America | $2.22M | 0.14 | 3,757 | -0.03% | -$590.90 | <0.0001 | |
| Group One Trading | $1.08M | 0.07 | 1,824 | -79.89% | -$4.28M | 0.03 | |
| Crewe Advisors | $547,000.00 | 0.04 | 925 | 0% | +$0 | 0.06 | |
| Wells Fargo | $260,000.00 | 0.02 | 440 | +18.6% | +$40,772.73 | <0.0001 | |
| First Manhattan Co. | $219,000.00 | 0.01 | 372 | 0% | +$0 | <0.01 | |
| Newbridge Financial Services Group Inc | $118,000.00 | 0.01 | 199 | 0% | +$0 | 0.05 | |
| Hollencrest Capital Management | $51,000.00 | <0.01 | 86 | 0% | +$0 | <0.01 | |
| Aspire Private Capital | $30,000.00 | <0.01 | 50 | 0% | +$0 | 0.01 | |
| Parallel Advisors, LLC | $17,000.00 | <0.01 | 28 | 0% | +$0 | <0.0001 | |
| Westside Investment Management Inc | $19,000.00 | <0.01 | 33 | 0% | +$0 | <0.01 | |
| National Bank Of Canada Fi | $9,000.00 | <0.01 | 33 | 0% | +$0 | <0.0001 | |
| Tsfg Llc | $0 | <0.01 | 3 | 0% | +$0 | <0.0001 | |
| PNC Financial Services | $8,000.00 | <0.01 | 12 | 0% | +$0 | <0.0001 |